Clinical Trial Update: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis

View source ↗

Summary

This entry notes completion of a clinical trial examining angiogenic and angiostatic mediators in patients with systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: University of Michigan | Conditions: Systemic Sclerosis | Status: COMPLETED